Vaxart, Inc.
VXRT· OTC
VXRTVaxart, Inc.
Filed Mar 15, 2023 · 10-K · 74 days after period end · 0001437749-23-006688
derived · Computed from the longer spans the company filed.
| Metric | Q4 2022dderived from reported figures | Q4 2021 | Q4 2020 | Q4 2019 |
|---|---|---|---|---|
| Revenue | $22.00K | $74.00K | $356.00K | $3.92M |
| Net Income | -$23.92M | -$20.76M | -$13.86M | -$6.41M |
| EPS Diluted | — | -$0.17 | -$0.13 | -$0.13 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Vaxart, Inc. · CIK 72444 · Engraved from SEC EDGAR
ended Dec 31, 2022 · filed Mar 15, 2023 · 74 d after period end
